ConductScience.org, home
Papers
API referenceFor AI assistants

Paper · 28042497

Regulation and role of post-translational modifications of enhancer of zeste homologue 2 in cancer development.

Lu H and 8 others. Am J Cancer Res, 2016. Cited by 39 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Regulation and role of post-translational modifications of enhancer of zeste homologue 2 in cancer development. Papers, record 28042497. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/28042497

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Regulation and role of post-translational modifications of enhancer of zeste homologue 2 in cancer development.
PubMed
Journal
Am J Cancer Res
PubMed
Year
2016
PubMed
Publication types
Review, Journal Article
PubMed
Citations, by iCite
39
iCite
Relative citation ratio, by iCite
1.26
iCite
Revised in PubMed
2020-10-01
PubMed

Authors9

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Lu HHaiqi
2Li GGuangliang
3Zhou CChenyi
4Jin WWei
5Qian XXiaoling
6Wang ZZhuo
7Pan HHongming
8Jin HHongchuan
9Wang XXian

Source PubMed

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Grants0

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

None in this release.

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References136

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
120,887,952TNF/p38α/polycomb signaling to Pax7 locus in satellite cells links inflammation to the epigenetic control of muscle regeneration.Cell Stem Cell2010https://conductscience.org/library/papers/20887952PubMed
225,734,985Roles of ubiquitination and SUMOylation on prostate cancer: mechanisms and clinical implications.Int J Mol Sci2015https://conductscience.org/library/papers/25734985PubMed
325,226,601Aberrant upregulation of 14-3-3σ and EZH2 expression serves as an inferior prognostic biomarker for hepatocellular carcinoma.PLoS One2014https://conductscience.org/library/papers/25226601PubMed
424,474,760O-GlcNAcylation regulates EZH2 protein stability and function.Proc Natl Acad Sci U S A2014https://conductscience.org/library/papers/24474760PubMed
527,147,466The role of post-translational modifications in hearing and deafness.Cell Mol Life Sci2016https://conductscience.org/library/papers/27147466PubMed
618,628,979The polycomb repressive complex 2 is a potential target of SUMO modifications.PLoS One2008https://conductscience.org/library/papers/18628979PubMed
724,526,064EZH2: not EZHY (easy) to deal.Mol Cancer Res2014https://conductscience.org/library/papers/24526064PubMed
817,362,198Functions of site-specific histone acetylation and deacetylation.Annu Rev Biochem2007https://conductscience.org/library/papers/17362198PubMed
925,800,736PCAF-primed EZH2 acetylation regulates its stability and promotes lung adenocarcinoma progression.Nucleic Acids Res2015https://conductscience.org/library/papers/25800736PubMed
1012,702,867Assembly of cell regulatory systems through protein interaction domains.Science2003https://conductscience.org/library/papers/12702867PubMed

1 to 10 of 136

See all 136 references

Cited by28

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 39 citations.

PMIDTitleJournalYearIn PapersSource
41,318,657RAD51B-EZH2 axis as a potential therapeutic target for TNBC through cell fate conversion.Cell Death Dis2025https://conductscience.org/library/papers/41318657PubMed
38,567,631The potential of EZH2 expression to facilitate treatment choice in stage II colorectal adenocarcinoma.Histol Histopathol2024https://conductscience.org/library/papers/38567631PubMed
38,494,860O-GlcNAc regulates anti-fibrotic genes in lung fibroblasts through EZH2.J Cell Mol Med2024https://conductscience.org/library/papers/38494860PubMed
37,475,584Downregulation of EZH2 inhibits epithelial-mesenchymal transition in enzalutamide-resistant prostate cancer.Prostate2023https://conductscience.org/library/papers/37475584PubMed
37,212,990Site-Directed Mutagenesis Protocol to Determine the Role of Amino Acid Residues in Polycomb Group (PcG) Protein Function.Methods Mol Biol2023https://conductscience.org/library/papers/37212990PubMed
36,672,374EZH2: An Accomplice of Gastric Cancer.Cancers (Basel)2023https://conductscience.org/library/papers/36672374PubMed
36,123,370Integrated analysis to study the interplay between post-translational modifications (PTM) in hepatitis C virus proteins and hepatocellular carcinoma (HCC) development.Sci Rep2022https://conductscience.org/library/papers/36123370PubMed
34,923,811Dysregulated Expression of Long Non-Coding RNA MINCR and EZH2 in Colorectal CancerIran Biomed J2022https://conductscience.org/library/papers/34923811PubMed
34,869,021Insights Into the Biological Role of NEDD4L E3 Ubiquitin Ligase in Human Cancers.Front Oncol2021https://conductscience.org/library/papers/34869021PubMed
34,745,848The Pivotal Immunomodulatory and Anti-Inflammatory Effect of Histone-Lysine N-Methyltransferase in the Glioma Microenvironment: Its Biomarker and Therapy Potentials.Anal Cell Pathol (Amst)2021https://conductscience.org/library/papers/34745848PubMed

1 to 10 of 28

See all 28 cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
EZH22,146PubTator's text mininghttps://conductscience.org/library/genes/2146NCBI Gene
PRDM956,979PubTator's text mininghttps://conductscience.org/library/genes/56979NCBI Gene

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/28042497

GET https://conductscience.org/api/papers/v1/28042497/references?page=2

API referenceFor AI assistants